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GFP Gene Targeting System
The components of the system we used to study gene targeting are depicted in
Fig. S1.  It is based on the correction by homologous recombination of a mutated green
fluorescent protein (GFP) gene (“GFP gene targeting system”).  A single copy of an
artificial gene target (A658) is stably integrated into the genome of 293 cells, creating
cell line “293/A658.”  The genomic target consists of a GFP gene that is mutated by the
insertion of an in-frame stop codon followed by the recognition site for the I-SceI
endonuclease (“Sce”) at basepair (bp) 327 of the GFP coding region. 293/A658 cells
remain GFP negative (data not shown).  We measured gene targeting by transfecting
293/A658 with a “substrate” construct that was promoter-less and missing the first 37
nucleotides, including the initiation codon, of the GFP gene ("RS2100" for repair
substrate with 2100 bp of homology). After transfection we measured the number of GFP
positive cells by flow cytometry and determined the rate of gene targeting by normalizing
the percentage of GFP positive cells to the transfection efficiency.  When we transfected
RS2100 into 293 cells without a gene target (293-0 cells) there were no GFP positive
cells (data not shown).  When we transfected supercoiled RS2100 alone into 293/A658,
the gene targeting rate was 7.1 x10-7, or 0.71 events per million transfected cells
(“spontaneous gene targeting or “S-GT”) (Fig. S1, B and C). We found that the frequency
of S-GT increased as the insertional mutation size in the GFP gene decreased (Fig. S1C).
We measured the double-stranded break induced gene targeting (DSB-GT) rate by
co-transfecting RS2100 with a Sce expression plasmid (see Fig. S1B for a representative
flow cytometry plot). Creating a DSB in the target GFP gene increased the rate of gene
targeting over 2000-fold (Fig. S1C).  Transfection of the Sce expression plasmid without
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the repair substrate RS2100 generated no GFP positive cells (Fig. S1B for a
representative flow cytometry plot).  Transfection of the Sce expression plasmid with the
repair substrate RS2100 into 293-0 cells did not generate GFP positive cells (data not
shown).  Unlike spontaneous gene targeting, the DSB-GT did not decrease as the
insertional mutation size increased (Fig. S1C).  We determined the time course of DSB-
GT by serially measuring the number of GFP positive cells after transfection and found
that the maximum number of GFP positive cells occurred 2.5-3 days after transfection
and remained stable for at least two weeks (Fig. S1D).  The gene targeting reaction,
therefore, occurred relatively quickly after transfection and created stable genetic change.
Finally, we purified single GFP positive cells by fluorescence activated cell sorting and
determined the sequence of the GFP gene after gene targeting. In the 9 GFP positive cells
tested, the sequence of the GFP gene was wild-type, demonstrating that gene targeting
had occurred (data not shown).  The DSB-GT rate in murine 3T3 and human SaOS-2
cells was similar to that in 293 cells (data not shown).   Further, the DSB-GT rate was
similar whether a pool of cells or a clonal cell line  with single insertion sites for A658
was examined (data not shown).  Thus, our findings were not cell type or integration site
dependent.
Using the GFP gene targeting system we quantitatively explored several variables
that regulate the rate of DSB-GT.   We found that increasing the amount of substrate
(RS2100) transfected increased the rate of DSB-GT until a plateau is reached (Fig. S2A).
This result demonstrated that gene targeting is dependent on the amount of repair
substrate available.  We found that increasing the length of homology between the repair
substrate and the target linearly increased the rate of DSB-GT (Fig. S2B).  In these
Porteus and Baltimore, Chimeric Nucleases and Gene Targeting
experiments we kept the amount of 5’ homology constant at 290 basepairs (bp) and
varied the amount of 3’ homology from 500 bp to 3700 bp.  This result suggests that
while spontaneous gene targeting is logarithmically dependent on homology length (S1),
DSB-GT is linearly dependent on homology length.  In either case, increasing the length
of homology between the target and the repair substrate increased the frequency with
which the cell undergoes gene targeting.  Figure S2C shows that the DSB-GT rate was
linearly dependent on the amount of PGK-Sce transfected.  The DSB-GT rate reached a
plateau, however, when higher amounts of CBA-Sce were transfected (Fig. S2C).  This
data suggests that DSB-GT is dependent on the creation of a DSB to initiate gene
targeting but eventually becomes saturated for DSB creation.  We found that
manipulating the transcriptional status of the repair substrate can affect the rate of gene
targeting.  Transcribing the truncated repair substrate with a CMV promoter (CMV-
RS2100) increased the rate of DSB-GT by 50% (Fig. S2D).  Just as with RS2100,
transfecting CMV-RS2100 into 293-0 cells did not generate GFP positive cells (data not
shown).  The rate of DSB-GT was highest when Sce expression is driven by the CBA
promoter, intermediate with the CMV promoter, and lowest with the PGK promoter (Fig.
S2E).  This result probably reflects the different levels of Sce expression from each
promoter.  Figure 1E also demonstrates that the rate of DSB-GT can be increased by
placing the repair substrate on the same plasmid as the Sce expression cassette rather than
co-transfecting two plasmids.  The stimulation was lost when the DSB-GT process was at
saturation, as when the CBA promoter was used to express Sce.  When we optimized the
above parameters we achieved  gene targeting rates of 3-5% which is a  20-fold increase
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over the DSB-GT rate obtained without optimization and gives an overall stimulation of
gene targeting by a DSB of over 40,000-fold.
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Fig. S1. GFP gene targeting system. A) Gene Targeting System.  The artificial gene
target (A658) consisted of a GFP gene mutated by a 35 basepair insertion which includes
a stop codon and a recognition site for the I-SceI endonuclease (Sce) (5’
TAGGGATAACAGGGTAAT  3’) at basepair 327 of the coding sequence.  The GFP
gene was driven by a hybrid cytomegalovirus enhancer/chicken β-actin promoter
(“CMV/CBA" or “CBA”).  The GFP gene was part of bicistronic transcript in which an
internal ribosomal entry site ("IRES") allowed translation of the human CD8α gene
(“CD8”).  The bicistronic message contained a Woodchuck post-trancriptional regulatory
element (“WPRE”) to increase messenger RNA levels (S2).  Finally, the locus contained
a gene with the phosphoglycerate kinase promoter (“PGK”) driving the neomycin
phosphotransferase gene (NEO) to allow selection by the antibiotic G418.  The repair
substrates RS2100 and RS2700 are also depicted.  They consisted of a GFP gene that has
been truncated at basepair 37 of the coding sequence and thus were missing the initiation
codon (“truncGFP”).  The truncated GFP gene was followed by the IRES-CD8 for
RS2100 or IRES-CD8-WPRE for RS2700 as in A658.  The A658 target gene was
introduced into 293 cells by electroporating 2 x 106 cells with 10 µg of supercoiled A658
plasmid DNA.  Cells were selected in 500 µg/ml G418 for two weeks.  Monoclonal cell
lines were made by picking individual colonies and identifying those with high surface
CD8 expression by staining with phycoerythrin-conjugated anti-CD8 antibody (BD
Biosciences, San Jose, CA) (293 cells normally do not express CD8).  Polyclonal cell
lines were made by purifying a population of cells using Miltenyi anti-CD8 microbeads
and a MACS mini-column (Miltenyi Biotec, Auburn, CA).  Gene targeting was measured
by transfecting 293/A658 cells with RS2100 with or without  a Sce expression plasmid
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along with  a control plasmid (pON405) to determine the transfection efficiency.  We
used three different promoters to drive Sce expression: PGK, cytomegalovirus (“CMV”),
and CBA.  The cells were then incubated for 3 days and the percentage of GFP positive
cells measured by flow cytometry using a FACScan (BD Biosciences, San Jose, CA).
The gene targeting rate was determined by normalizing the measured percentage of GFP
positive cells to the transfection efficiency.  B)  Representative Flow Cytometry Plots of
Gene Targeting.  GFP positive cells were quantitated in region “R2” as depicted in the
right flow plot.  The left plot, “S-GT,” shows 293/A658 cells after transfection with
RS2100 alone.  The two GFP positive cells are circled and represent spontaneous gene
targeting events.   The middle plot, “DSB-GT,” shows 293/A658 cells after co-
transfection with RS2100 and CBA-Sce.  In this plot there are numerous GFP positive
cells in region R2.  The right plot shows 293/A658 cells after transfection with Sce
expression plasmid alone.  There are no GFP positive cells.  C)  Gene Targeting Rates in
293 Cells.  The results are shown as both the number of gene targeting events per million
transfected cells ("Events/106 cells") plus/minus one standard deviation and as an overall
rate.   The results are shown for four different gene targets.    In the "1bp mutation"
target, a nonsense mutation was created in the GFP gene at bp 321 of the coding region
that abrogates functional GFP expression.  For the “7 bp insertion” target, a 7 bp
sequence was inserted at bp 327 of the GFP coding region.  The gene target for the “35
bp insertion” was A658 and the target for the “66 bp insertion” was QQR8 (schematized
in Figure 1B).  The row labeled "Sce" shows whether Sce was co-transfected or not.
The column labeled "Fold Stimulation by Sce Induced DSB" was the stimulation of the
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gene targeting rate on target A658 induced by expression of Sce.  D) Time Course of
Gene Targeting.  The relative rate of DSB-GT was normalized to day 3.
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Fig. S2. Parameters regulating the rate of DSB-induced gene targeting. In these
experiments, transfections were performed by the calcium phosphate technique in 24-
well plates. In plots A-D, the rates of gene targeting were normalized to the standard
conditions of using 200 nanograms (ng) of RS2100 and 200 ng of PGK-Sce.  In
experiments where the amount of a transfected component was varied, the total DNA
amount was kept constant by adding pBSK(-) plasmid (Stratagene, La Jolla, CA).  A)
Gene Targeting Rate vs. Substrate Amount.  The results were normalized to the rate of
gene targeting obtained after transfecting 200 ng of RS2100.  B) Gene Targeting Rate vs.
Homology Length.  The results were normalized to the rate obtained with plasmid
RS2100.  The plasmid with 800 bp of homology (RS800) was missing the IRES-CD8
component of RS2100.  The plasmid with 2700 bp of homology (RS2700) is depicted in
Fig. S1A.  The plasmid with 4200 bp of homology (RS4200) had the addition of both the
WPRE and the PGK-NEO components to the 3’ end of RS2100.  A constant amount (200
ng) of each repair substrate was transfected but the relative rate of DSB-GT was
normalized to the molar amount transfected.  C) Gene Targeting Rate vs. Amount of Sce
Expression Plasmid Transfected.  The results were normalized to the rate of gene
targeting obtained when 200 ng of PGK-Sce was transfected. D)  Gene Targeting Rate vs.
Transcriptional Status of Repair Substrate.  “Untranscribed” was the rate of DSB-GT
using RS2100.  “Transcribed” was the rate of DSB-GT when the sense strand of RS2100
was transcribed using the CMV promoter (CMV-RS2100).  The rates were normalized to
the rate of gene targeting obtained using RS2100.  E) Optimization of Gene Targeting.
Columns labeled “1” are when Sce and RS2100 are on the same plasmid and columns
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labeled “2” are when Sce and RS2100 are on separate plasmids.  30,000 GFP positive
cells per million transfected cells is equivalent to a gene targeting rate of 3%.
Abbreviations:  CBA, cytomegalovirus enhancer/chicken beta-actin promoter; PGK,
phosphoglycerate kinase promoter; Sce, I-SceI endonuclease, CMV, human
cytomegalovirus early enhancer/promoter.
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